European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai

by | Jul 26, 2024 | Consumer Products, FEATURED, HEADLINE, Investing, Stocks

European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating another hurdle for the companies as …

FEATURED